MedPath

Direct Bypass Versus Indirect Bypass in Treatment of Adults Hemorrhagic Moyamoya Disease

Not Applicable
Conditions
Moyamoya Disease
Registration Number
NCT02982135
Lead Sponsor
liuxingju
Brief Summary

The investigators conducted a prospective multi-center study assessing the effect of direct bypass and indrect bypass in treatment of hemorrhagic moyamoya disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  1. cerebral digital subtraction contrast angiography (DSA) revealed severe stenosis or occlusion of the distal internal carotid or proximal middle and anterior cerebral arteries with prominent lenticulostriate "moyamoya collaterals"
  2. patients had experienced at least one intracranial hemorrhage which was verified by computed tomography (CT) scanning, magnetic resonance imaging MRI), or lumbar puncture.
  3. Patients requiring surgery
Exclusion Criteria
  1. Patient whose initial onset was marked by ischemia but subsequently suffered from intracranial hemorrhage
  2. patients refused to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
rebleeding events5-10 years
Secondary Outcome Measures
NameTimeMethod
postoperative compilications30 days
ischemic events5-10 years

Trial Locations

Locations (1)

Beijing Tiantan Hospital Capital Medical University

🇨🇳

Beijing, Beijing, China

Beijing Tiantan Hospital Capital Medical University
🇨🇳Beijing, Beijing, China
liu xingju, MD
Contact
008615011476305
liuxingju006@163.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.